openPR Logo
Press release

At a CAGR of 6.7%, Thrombosis Drugs Market Size Will Estimated to Reach USD 51.5 Billion by 2031 | TMR Research

07-31-2024 01:37 PM CET | Health & Medicine

Press release from: Transparency Market Research

Thrombosis Drugs Market

Thrombosis Drugs Market

Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. It can lead to serious conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke. Effective treatment and prevention of thrombosis are critical to reduce morbidity and mortality. This article explores the current state, trends, and future prospects of the thrombosis drugs market.

Thrombosis Drugs Market (혈전증 약물 시장) is estimated to grow at a CAGR of 6.7% from 2023 to 2031 and reach US$ 51.5 Bn by the end of 2031

Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=46293

Overview of Thrombosis Drugs Market
The global thrombosis drugs market is growing due to an increasing prevalence of thrombotic disorders, advancements in anticoagulant therapies, and a rising awareness of the importance of early detection and treatment. The market is segmented by drug type (anticoagulants, antiplatelet drugs, thrombolytics, others), indication (DVT, PE, atrial fibrillation, myocardial infarction, others), route of administration (oral, injectable), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies), and geographical regions.

Top Companies:

GSK plc
Baxter International Inc.
Johnson & Johnson
Sanofi
Bristol-Myers Squibb Company
AstraZeneca plc
Bayer AG
Aspen Pharmacare Holdings Limited
Boehringer Ingelheim GmbH Pfizer, Inc.

Recent Developments in Thrombosis Drugs Market
Recent advancements and trends in the thrombosis drugs market include:

Novel Oral Anticoagulants (NOACs): Development and increasing use of NOACs such as rivaroxaban, apixaban, and dabigatran, which offer advantages over traditional warfarin in terms of safety and ease of use.
Combination Therapies: Exploration of combination therapies that incorporate anticoagulants with antiplatelet drugs to enhance efficacy in preventing thrombotic events.
Biosimilars: Introduction of biosimilars for established anticoagulants, providing cost-effective treatment options.
Personalized Medicine: Growth in personalized medicine approaches to tailor thrombosis treatments based on individual patient risk profiles and genetic factors.
Extended-Release Formulations: Development of extended-release formulations to improve patient compliance by reducing the frequency of dosing.

Drivers of Market Growth
Several factors contribute to the growth of the thrombosis drugs market:

Rising Incidence of Thrombotic Disorders: Increasing prevalence of conditions such as DVT, PE, atrial fibrillation, and cardiovascular diseases driving the demand for thrombosis drugs.
Aging Population: Aging population more susceptible to thrombotic disorders due to age-related changes in the coagulation system and increased prevalence of comorbidities.
Advancements in Anticoagulant Therapy: Continuous advancements in anticoagulant therapies enhancing the efficacy and safety of thrombosis treatments.
Increased Awareness: Growing awareness about the importance of early detection and treatment of thrombotic disorders among healthcare professionals and patients.
Improved Diagnostic Technologies: Advancements in diagnostic technologies facilitating early and accurate diagnosis of thrombotic conditions, leading to timely treatment.

Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=46293

Conclusion

The thrombosis drugs market is poised for significant growth, driven by rising incidence of thrombotic disorders, aging population, advancements in anticoagulant therapy, increased awareness, and improved diagnostic technologies. Innovations in NOACs, combination therapies, biosimilars, personalized medicine, and extended-release formulations are enhancing the potential and efficacy of thrombosis treatments.

Market Segmentation

Drug Class
Factor Xa Inhibitor
Low Molecular Weight Heparin
P2Y12 Platelet Inhibitor
Others

Indication
Pulmonary Embolism
Atrial Fibrillation
Deep Vein Thrombosis
Others

Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regions Covered
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=46293<ype=S

More Trending Reports by Transparency Market Research -

Cryotherapy Market (Marché de la cryothérapie): https://www.globenewswire.com/en/news-release/2024/07/03/2908096/32656/en/Cryotherapy-Market-to-be-Worth-USD-885-7-million-by-2034-Growing-a-CAGR-9-3-Exclusive-Report-by-Transparency-Market-Research-Inc.html

Urinary Tract Disorders Propels Ureteral Stents Market (尿路疾患が尿管ステント市場を牽引): https://www.globenewswire.com/news-release/2024/07/05/2909009/32656/en/Rising-Incidence-of-Urinary-Tract-Disorders-Propels-Ureteral-Stents-Market-to-Achieve-USD-823-7-Million-by-2031-Transparency-Market-Research-Inc.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release At a CAGR of 6.7%, Thrombosis Drugs Market Size Will Estimated to Reach USD 51.5 Billion by 2031 | TMR Research here

News-ID: 3605687 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for Thrombosis

Rising Demand For Deep Vein Thrombosis (DVT) Treatment Drives Market Growth: Key …
The Deep Vein Thrombosis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Deep Vein Thrombosis Market Size During the Forecast Period? The Deep Vein Thrombosis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025
Deep Vein Thrombosis Market Size, Share, Development By 2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company offers in-depth market insights through Deep Vein Thrombosis Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments. Market Size And Growth Forecast: The deep vein thrombosis market size has grown steadily in recent
Thrombosis Drug Market Stunning Value Ahead | GlaxoSmithKline , Baxter, Johnson …
The latest study released on the Global Thrombosis Drug Market by HTF MI evaluates market size, trend, and forecast to 2029. The Thrombosis Drug market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players in
Thrombosis Drugs Market to Eyewitness Massive Growth by 2032
Thrombosis, the formation of blood clots within blood vessels, is a condition that can have serious and life-threatening consequences. In the quest to combat this medical challenge, the Thrombosis Drugs Market plays a vital role in shaping the dynamics from initial research to patient recovery. This article dives deep into the evolving landscape of thrombosis treatment, highlighting the progress, challenges, and the critical role of research in achieving recovery. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞
Thrombosis Associated with Cancer Market Insights, Forecast to 2030
Thrombosis Associated with Cancer Market 2021 by Technology, Manufacturers, Regions, Type, and Application, Forecast guide to light the excellent analysis on the market synopsis. The report offers a primary focus on important factors in the global Thrombosis Associated with Cancer industry. The report includes perceptive information about gross revenue, cost, value, capacity, pricing, and profit margins concerning historical analysis and forecast estimation for the 2021 to 2031 time period. It
Thrombosis Drugs Market
“Thrombosis Drugs Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market